Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imagine Pharma has developed a proprietary IMG‑1 polypeptide with applications across oral delivery of biologics, regenerative medicine, and direct therapeutics. The company has achieved significant scientific milestones in preclinical models and recently launched a dietary supplement while advancing toward clinical development in metabolic diseases such as diabetes. It was also selected as an Islet Isolation Center by the National Institute of Diabetes and Digestive and Kidney Diseases Integrated Islet Distribution Program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imagine Foundations.